Exact Sciences | EXAS - Bruttoergebnis Vom Umsatz

Aktienkurs
104.94
Täglich Wechseln
1.02 0.98%
Monatlich
1.50%
Jährlich
130.03%
Q1 Prognose
100.44




Bruttoergebnis Vom Umsatz Veränderung Datum
Agilent USD 946M 44M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Bio Techne USD 191.28M 3.16M 2025-12
Bio-Rad Laboratories USD 343.4M 1.9M 2025-09
Bruker USD 449.2M 69.8M 2025-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Danaher USD 3.97B 443M 2025-12
Exact Sciences USD 583.93M 21.48M 2025-09
Hologic USD 586.4M 2.9M 2025-12
Illumina USD 759M 26M 2025-12
Mesa Laboratories USD 39.75M 4.3M 2024-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Quidel USD 274.8M 1.01B 2025-12
Repligen USD 103.83M 3.32M 2025-12
Revvity USD 421.66M 47.06M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Veracyte USD 101.97M 10.69M 2025-12
Waters USD 557.42M 97.44M 2025-12